Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response

Authors: Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Olga Martínez-Sáez, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco Pardo, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, Maria Vidal, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira

Source: Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/7c7d4486147e4021ad5651e0e2b54a88

Early Myocardial Strain Reduction and miR-122-5p Elevation Associated with Interstitial Fibrosis in Anthracycline-Induced Cardiotoxicity

Authors: María de Regla Caballero-Valderrama, Elisa Bevilacqua, Miriam Echevarría, Francisco Javier Salvador-Bofill, Antonio Ordóñez, José Eduardo López-Haldón, Tarik Smani, Eva M. Calderón-Sánchez

Source: Biomedicines, Vol 13, Iss 1, p 45 (2024)

Subject Terms: cardiotoxicity, anthracycline, epirubicin, global longitudinal strain, circumferential strain, myocardial fibrosis, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2227-9059/13/1/45; https://doaj.org/toc/2227-9059

Access URL: https://doaj.org/article/c24e4e021cd74902a6f3f7b241def8b6

SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer

Authors: Tomás Pascual, Mafalda Oliveira, Eva Ciruelos, Meritxell Bellet Ezquerra, Cristina Saura, Joaquin Gavilá, Sonia Pernas, Montserrat Muñoz, Maria J. Vidal, Mireia Margelí Vila, Juan M. Cejalvo, Blanca González-Farré, Martin Espinosa-Bravo, Josefina Cruz, Francisco Javier Salvador-Bofill, Juan Antonio Guerra, Ana María Luna Barrera, Miriam Arumi de Dios, Stephen Esker, Pang-Dian Fan, Olga Martínez-Sáez, Guillermo Villacampa, Laia Paré, Juan M. Ferrero-Cafiero, Patricia Villagrasa, Aleix Prat

Source: Frontiers in Oncology, Vol 11 (2021)

Subject Terms: Breast Cancer, ERBB3, HER3, U3-1402, patritumab deruxtecan, HER3-DXd, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.638482/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/0fe8923a3c164bc1a60918d97253ce3e

Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study

Authors: José Enrique Alés-Martínez, Judith Balmaña, Pedro Sánchez-Rovira, Francisco Javier Salvador Bofill, Jose Ángel García Sáenz, Isabel Pimentel, Serafín Morales, María Fernández-Abad, Ainhara Lahuerta Martínez, Neus Ferrer, Pilar Zamora, Begoña Bermejo, Tamara Díaz-Redondo, María Helena López-Ceballos, María Galán, Jhudit Pérez-Escuredo, Laura Calabuig, Miguel Sampayo, José Manuel Pérez-Garcia, Javier Cortés, Antonio Llombart-Cussac

Source: Breast, Vol 77, Iss , Pp 103780- (2024)

Subject Terms: HER2-Positive, Advanced breast cancer, BRCA mutation, Olaparib, Trastuzumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S0960977624001115; https://doaj.org/toc/1532-3080

Access URL: https://doaj.org/article/19f49dc9a9694e038d227468d5e24fe9

Assessment of Prognostic and Therapeutic Factors in Male Breast Cancer: An Observational Study of a Southwest Spanish Single Center

Authors: Daniel Herrero, María Rocío Morales Herrero, José Luis López Guerra, Alberto Sánchez Camacho-Mejías, Irene Carrasco García, Paloma Santos Fernández, Carmen Victoria Almeida González, Marta Benavent Viñuales, Alejandro Falcón González, Álvaro Montaño Periáñez, Rosario González Mancha, Francisco Javier Salvador Bofill, Manuel Ruiz Borrego

Source: Archives of Breast Cancer (2020)

Subject Terms: Breast Cancer, BRCA, Endocrine therapy, Male breast cancer, Prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.archbreastcancer.com/index.php/abc/article/view/313; https://doaj.org/toc/2383-0433

Access URL: https://doaj.org/article/027c49113f9b4b1c8ba36b809b762643